Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Equity Ratio (2022 - 2025)

Historic Equity Ratio for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to 0.42.

  • Orchestra BioMed Holdings' Equity Ratio fell 3199.16% to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42, marking a year-over-year decrease of 3199.16%. This contributed to the annual value of 0.43 for FY2024, which is 3945.64% down from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Equity Ratio stood at 0.42 for Q3 2025, which was down 3199.16% from 0.01 recorded in Q2 2025.
  • Over the past 5 years, Orchestra BioMed Holdings' Equity Ratio peaked at 0.73 during Q1 2023, and registered a low of 0.09 during Q3 2022.
  • Over the past 4 years, Orchestra BioMed Holdings' median Equity Ratio value was 0.55 (recorded in 2022), while the average stood at 0.42.
  • Per our database at Business Quant, Orchestra BioMed Holdings' Equity Ratio soared by 279957.67% in 2023 and then plummeted by 9887.0% in 2025.
  • Orchestra BioMed Holdings' Equity Ratio (Quarter) stood at 0.55 in 2022, then skyrocketed by 30.01% to 0.71 in 2023, then crashed by 39.46% to 0.43 in 2024, then dropped by 3.55% to 0.42 in 2025.
  • Its last three reported values are 0.42 in Q3 2025, 0.01 for Q2 2025, and 0.29 during Q1 2025.